Nashville, Tennessee


This study evaluates a mobile phone-delivered intervention, called REACH (Rapid Education/Encouragement And Communications for Health), in supporting adults with type 2 diabetes in their self-management relative to a control group. The goal of this study is to determine if individually tailored content (based on the Information-Motivation-Behavioral Skills Model) delivered to the participant via text messages can improve the participant's glycemic control and adherence to diabetes medications. We will test whether our intervention improves adherence-related information, motivation, and behavioral skills and whether improving these mechanisms drives improvements in adherence and, in turn, glycemic control.


Inclusion Criteria: - Adults aged 18 years and older - Individuals who have received a diagnosis for type 2 diabetes mellitus - Enrolled as a patient at a participating community health center - Individuals currently being treated with oral and/or injectable diabetes medications Exclusion Criteria: - Non-English speakers - Individuals who report they do not have a cell phone - Individuals unwilling and/or not able to provide written informed consent - Individuals with unintelligible speech (e.g., dysarthria) - Individuals with a severe hearing or visual impairment - Individuals who report a caregiver administers their diabetes medications Individuals who fail the cognitive screener administered during the baseline survey - Individuals who cannot receive, read, and respond to a text after instruction from a trained research assistant - Individuals whose most recent (within 12 months) HbA1c value was 6.8% or greater



Primary Contact:

Principal Investigator
Lindsay S Mayberry, MS, PhD
Vanderbilt University Medical Center

Erin M Bergner, MPH, MA
Phone: 615-936-7640

Backup Contact:


Location Contact:

Nashville, Tennessee
United States

Lyndsay Nelson, PhD

Site Status: Recruiting

Data Source:

Date Processed: November 20, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.